The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.
Lucy DengCatherine GloverMichael DymockAlexis PillsburyJulie A MarshHelen E QuinnAlan LeebPatrick CashmanThomas L SnellingNicholas WoodKristine MacartneyPublished in: The Medical journal of Australia (2022)
AusVaxSafety active surveillance affirms the short term safety profile of Comirnaty and Vaxzevria vaccines in a large population sample during the first six months of the Australian COVID-19 vaccination program.